Company Encyclopedia
View More
name
Bright Green
BGXX.US
Bright Green Corporation produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States. Its products are used in research, manufacturing, and export, as well as for production of medical cannabis products and preparations. The company was incorporated in 2019 and is based in Grants, New Mexico. On February 22, 2025, Bright Green Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S.
4.722 T
BGXX.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    PharmAGRI Capital Partners Targets $10 Billion Federal Procurement Opportunity for Onshored Plant-Based Prescription Drugs Bright Green Corporation "BGXXQ" Q and A

    Fort Lauderdale, FL, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- PharmAGRI Capital Partners today announced its strategic focus on capturing a $10 billion total addressable market ( TAM ) in federal procurement of plant-based prescription drugs currently sourced from foreign manufacturers.

    GlobeNewswire·
    US
    BGXXQ
    0.00%
    US
    BGXX
    0.00%
    GlobeNewswire·
    US
    BGXXQ
    0.00%
    US
    BGXX
    0.00%

    Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman | BGXX Stock News

    Bright Green Corporation has merged with PharmAGRI Capital Partners, with Lynn Stockwell appointed as CEO and Chairwoman. The merger aims to restore U.S. drug manufacturing sovereignty and will consolidate various licenses and registrations under a court-supervised restructuring. PharmAGRI plans to deploy Tesla robotics for drug manufacturing, enhancing compliance and creating high-wage jobs. The company intends to file for Nasdaq relisting and complete an IPO by the end of 2025, focusing on federal contracts and expanding U.S. pharmaceutical infrastructure.

    StockTitan·
    US
    BGXX
    0.00%
    StockTitan·
    US
    BGXX
    0.00%

    Bright Green Corp shifts from cannabis to DEA Schedule Controlled Substances, completes restructuring plan, as per RSA agreement, pays creditors in full, retains equity interest, no dilution for shareholders.

    In Fort Lauderdale, Florida, on February 24, 2025, Bright Green Corporation (OTC: BGXX) revealed a significant development. Lynn Stockwell, representing the Company, has formally requested court approval for the "RSA" Restructuring Security Agreement. The main points of the RSA involve securing fresh equity to fully settle all outstanding debts with authorized claims, ensuring that the Company's existing equity shareholders maintain their ownership stakes without any reduction or dilution.

    Unusual Whales·
    US
    BGXXQ
    0.00%
    US
    BGXX
    0.00%
    Unusual Whales·
    US
    BGXXQ
    0.00%
    US
    BGXX
    0.00%

    Bright Green Corp exits Cannabis, focuses on DEA Controlled Substances post restructuring; creditors to receive full payment. Lynn Stockwell leads RSA for equity retention.

    On February 24, 2025, in Fort Lauderdale, Florida, Bright Green Corporation (OTC: BGXX) disclosed its proposal for the "RSA" Restructuring Security Agreement through Lynn Stockwell, requesting court approval. This agreement aims to secure fresh equity facilitating full payment to all verified creditors and ensuring existing Company equity shareholders maintain their stake without any dilution or impairment.

    Unusual Whales·
    US
    BGXX
    0.00%
    Unusual Whales·
    US
    BGXX
    0.00%

    Bright Green Corporation completes restructuring, exits Cannabis business, opts for DEA Controlled Substances. $XX equity for creditors, shareholders remain unimpaired.

    In Fort Lauderdale, Florida, on February 24, 2025, Bright Green Corporation (OTC: BGXX) disclosed that Lynn Stockwell, representing the company, has filed for court approval of the "RSA" Restructuring Security Agreement. The RSA aims to secure fresh equity for the company to settle all outstanding debts to verified creditors entirely. Furthermore, existing equity shareholders of the Company will maintain their ownership stakes without any reduction or dilution.

    Unusual Whales·
    US
    BGXX
    0.00%
    Unusual Whales·
    US
    BGXX
    0.00%
    © 2025 Longbridge｜Disclaimer